Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Hepatogastroenterology ; 52(62): 420-4, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15816448

RESUMO

BACKGROUND/AIMS: To determine the relationship of basal ganglia alterations demonstrated on brain MRI and clinical presentation, evaluated with Child-Pugh score, using Color Doppler Ultrasonography parameters of portal hemodynamics in cirrhotic patients with signs of portal hypertension. METHODOLOGY: Twenty randomly selected cirrhotic patients (16 males and 4 females with a mean age of 63.6+/-8.9 years) classified according to Child-Pugh score (grade A=16 patients, grade B=4), were submitted to Color Doppler US evaluation of hepatic flow and brain MRI. The obtained flow parameters were: PVD, PVCSA, MPVF, MPVFV, HAD, MHAF, hepatic artery RI, CI and MHI. The basal ganglia signal intensity, on T1-weighted images on brain MRI was evaluated both qualitatively (normal, mild, moderate and severe) and quantitatively with the ROI method. RESULTS: Among Color Doppler parameters, only the CI exhibited a modest correlation with the Child's clinical score (p for linear trend by ANOVA <0.05). Subjective MRI grading demonstrated an excellent correlation with the qualitative assessment of signal density (Spearman p=0.95, p<0.01). When signal intensity on T1-weighted images was analyzed as a continuous variable with normal distribution and ultrasonographic parameters as possible determinants, the portal vein diameter (PVD) and consequently the cross-sectional area (PVCSA) emerged as the sole predictor of MR signal intensity (Pearson's r=0.58, p=0.01). CONCLUSIONS: Although this is a preliminary study and further research should be performed including a larger number of patients, it suggests that Color Doppler US might play a prognostic role in predicting hepatocellular dysfunction and hepatic encephalopathy.


Assuntos
Encéfalo/patologia , Circulação Hepática , Cirrose Hepática/diagnóstico , Cirrose Hepática/fisiopatologia , Imageamento por Ressonância Magnética , Ultrassonografia Doppler em Cores , Idoso , Gânglios da Base/patologia , Feminino , Humanos , Cirrose Hepática/diagnóstico por imagem , Masculino , Pessoa de Meia-Idade , Índice de Gravidade de Doença
2.
Int J Impot Res ; 16(1): 2-7, 2004 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-14963464

RESUMO

The aim of the study was to establish and compare the efficacy and safety of sildenafil and apomorphine in men with arteriogenic erectile dysfunction (ED). In all, 43 men with ED and postinjection max penile systolic velocity <25 cm/s in repeated Doppler ultrasonography were included. Of these, 24 men started on apomorphine 2 mg and 19 on sildenafil 50 mg, the doses titrated up to 3 and 100 mg according to effectiveness and tolerability. Safety was evaluated according to adverse events (AEs) and patient withdrawal. Efficacy was the percentage of attempts resulting in erections firm enough for intercourse, based on event log data. The incidence of AEs with apomorphine 3 mg was higher than with sildenafil 100 mg. Two men on apomorphine 3 mg discontinued treatment due to AEs. The overall success rate of sildenafil was 63.7% compared to 32.1% of apomorphine (Pearson chi(2), P<0.01). Of all men, 25 (58.1%) responded to sildenafil 50 mg without the need for dose increase, while only one responded to apomorphine 2 mg. The response to sildenafil 50 mg was age related (analysis of variance, p=0.04). Satisfaction was reported by 76.75 and 13.95% of patients for sildenafil and apomorphine, respectively, but 20.9% were not satisfied with any of the two drugs. In conclusion, this study provides clear evidence that sildenafil, even at 50 mg dose, is more effective than apomorphine 3 mg in men with arteriogenic ED. The fact that one out of five patients is not satisfied with the above-studied drugs shows that new oral agents need to be evaluated for the treatment of this disorder.


Assuntos
Apomorfina/administração & dosagem , Agonistas de Dopamina/administração & dosagem , Disfunção Erétil/tratamento farmacológico , Piperazinas/administração & dosagem , Vasodilatadores/administração & dosagem , Apomorfina/efeitos adversos , Artérias , Estudos Cross-Over , Agonistas de Dopamina/efeitos adversos , Disfunção Erétil/etiologia , Humanos , Masculino , Pessoa de Meia-Idade , Satisfação do Paciente , Piperazinas/efeitos adversos , Purinas , Citrato de Sildenafila , Sulfonas , Resultado do Tratamento , Doenças Vasculares/complicações , Vasodilatadores/efeitos adversos
3.
J Endourol ; 14(3): 257-61, 2000 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10795615

RESUMO

PURPOSE: To evaluate the efficacy of alcohol in combination with tetracycline for the treatment of symptomatic renal cysts. PATIENTS AND METHODS: Twenty-four patients age 45 to 77 years (mean 66 years) with a large (5-13-cm; mean 7.5-cm) symptomatic renal cyst associated with flank pain were treated by aspiration under ultrasound guidance and injection of alcohol and tetracycline. Patients were followed with ultrasonography at 1, 6, and 12 months and once a year thereafter. RESULTS: The aspirated volume ranged from 65 to 1500 mL (mean 360.5 mL). Two patients experienced mild pain during alcohol injection, but the procedure was completed successfully. One patient reported severe pain after tetracycline injection. The tetracycline was immediately aspirated, and the procedure was then aborted. The remaining patients were relieved of their symptoms after treatment, and they remained symptom free during a mean follow-up of 20 months (range 7-36 months). CONCLUSIONS: The combination of alcohol and tetracycline is safe and effective and offers a very favorable minimally invasive therapeutic alternative for the treatment of symptomatic renal cysts.


Assuntos
Etanol/uso terapêutico , Doenças Renais Císticas/terapia , Sucção , Tetraciclina/uso terapêutico , Idoso , Diagnóstico Diferencial , Quimioterapia Combinada , Feminino , Humanos , Injeções Intralesionais , Doenças Renais Císticas/diagnóstico , Masculino , Pessoa de Meia-Idade , Pacientes Ambulatoriais , Resultado do Tratamento
4.
J Endourol ; 15(10): 993-6, 2001 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11789982

RESUMO

PURPOSE: We report on our experience with the use of metal stents for the treatment of atherosclerotic renovascular disease. PATIENTS AND METHODS: Since 1996, 62 patients (mean age 67 years) with ostial atherosclerotic renal artery stenosis were treated successfully by placement of metal stents. All patients presented with renovascular hypertension, and eight had additionally impaired renal function. In 12 patients, stents were placed bilaterally. In 54 patients, the introduction of stents was performed as the primary mode of treatment, and in the remaining 8 patients, the positioning of the endoprosthesis was deemed necessary because of recurrence of stenosis previously treated by renal percutaneous transluminal angioplasty (PTA). The patients were followed for a mean period of 18 months (range 9-48 months). RESULTS: Positioning of the endoprosthesis was successful in all patients. No major complications were reported. The 18-month patency rate was 77.4% (48 patients). Hypertension resolved in 39 patients and showed a trend to improvement in 15 patients. We observed no improvement of renal function in the eight patients who had impaired function prior to the procedure. CONCLUSION: Implantation of metal stents is a safe and effective method for the treatment of atherosclerotic renal artery stenosis and certainly presents an important alternative to renal PTA.


Assuntos
Obstrução da Artéria Renal/terapia , Stents , Idoso , Angioplastia Coronária com Balão , Arteriosclerose/terapia , Humanos , Metais , Radiografia , Artéria Renal/diagnóstico por imagem , Obstrução da Artéria Renal/diagnóstico por imagem , Resultado do Tratamento , Grau de Desobstrução Vascular
5.
J Endourol ; 14(9): 743-7, 2000 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11110569

RESUMO

PURPOSE: In vitro preparation of liposome-covered metal stents and loading of liposomal drug formulations that will slowly release the drug in the vicinity of the stent. MATERIALS AND METHODS: Polytetrafluoroethylene-coated stents were used. Large multilamellar (MLV) liposomes (phosphatidylcholine:cholesterol 1:1 mol/mol), empty or entrapping the corticosteroid anti-inflammatory drug, dexamethasone, were prepared by the thin-film hydration method and applied to pieces of stent using a simple and mild evaporation technique. Initially, a freeze-drying method for applying liposomes to stents was also evaluated, but it failed to produce stents that efficiently retain liposomal lipid when incubated in an aqueous environment. The presence of liposomes on the stent surface was confirmed by scanning electron microscopy. RESULTS: After analyzing the release of liposomal lipid (using a phospholipid assay) and liposomal drug (by a modified dexamethasone high-pressure liquid chromatography method) in an in vitro system developed to simulate in vivo conditions, it was found that 39.11+/-6.8% of the lipid and 50.84+/-5.48% of the drug was released from the stent pieces during 48 hours of incubation in the presence of artificial urine. The amount of dexamethasone released from stents during their application procedure was found to be negligible in an in vitro dry run. CONCLUSION: The use of stent-associated liposomal drug formulations as slow-release depots could be an efficient method of treating the untoward event of ureteral stent obstruction.


Assuntos
Materiais Revestidos Biocompatíveis , Dexametasona/administração & dosagem , Glucocorticoides/administração & dosagem , Metais , Politetrafluoretileno , Implantação de Prótese/instrumentação , Ureter/cirurgia , Cromatografia Líquida de Alta Pressão , Dexametasona/análise , Implantes de Medicamento , Glucocorticoides/análise , Humanos , Técnicas In Vitro , Lipossomos/química , Obstrução Ureteral/tratamento farmacológico , Obstrução Ureteral/etiologia , Obstrução Ureteral/cirurgia
6.
Urol Int ; 76(3): 285-7, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16601397

RESUMO

A case of isolated, bilateral, adrenal tuberculosis is presented. A 25-year-old male was admitted to the hospital due to lumbar pain, fever, weight loss and anorexia. Abdominal ultrasonography and computed tomography demonstrated bilateral adrenal enlargement. Laboratory investigations were remarkable for adrenal insufficiency. The Mantoux reaction was positive but there was no evidence of lung or urinary infection. CT-guided biopsy of the left adrenal gland was performed and established the diagnosis of adrenal tuberculosis.


Assuntos
Doenças das Glândulas Suprarrenais/diagnóstico por imagem , Doenças das Glândulas Suprarrenais/patologia , Tomografia Computadorizada por Raios X , Tuberculose Endócrina/diagnóstico por imagem , Tuberculose Endócrina/patologia , Doenças das Glândulas Suprarrenais/microbiologia , Adulto , Biópsia/métodos , Humanos , Masculino
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa